Source: ERS Lung Science Conference 2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Doherty Declan (Belfast, United Kingdom). Mesenchymal stem cell therapy reduces inflammation and damage in a model of chronic lung disease. ERS Lung Science Conference 2017

Member's Comments

No comment yet.

Related content which might interest you: Mesenchymal stem cell therapy in a model of chronic inflammatory lung disease Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Mesenchymal stromal (stem) cell therapy modulates miR-193b-5p expression to attenuate sepsis-induced acute lung injury Source: Eur Respir J, 59 (1) 2004216; 10.1183/13993003.04216-2020 Year: 2022 The therapeutic potential of the mesenchymal stem cell secretome in a mouse model of chronic inflammatory lung disease Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Mesenchymal stem cell therapy for severe emphysema Source: ERS Lung Science Conference 2021 Year: 2021 Mesenchymal stem cell therapy for severe emphysema Source: Virtual Congress 2021 – Repair and regeneration in chronic lung disease and lung cancer Year: 2021 Mesenchymal stem cell based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysacharride in mice Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury Year: 2008 Mesenchymal stem cells and fibrotic lung diseases Source: International Congress 2014 – Targeting lung fibrosis: from bench to bedside Year: 2014 Stem cell therapy attenuates airway and lung parenchyma remodeling in a murine model of chronic allergic asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 Immunotherapeutic strategy with mesenchymal stem cells modulating inflammation in an experimental model of COPD. Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020 Mesenchymal stem cells prevent early inflammation in a rat model of ventilator induced lung injury Source: Annual Congress 2011 - Mechanisms of acute lung injury and mesenchymal cell treatment Year: 2011 Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells Source: Eur Respir J 2012; 39: 446-457 Year: 2012 Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease Year: 2015 Human mesenchymal stem cell exosomes attenuate inflammation of lung epithelial cells through miR-223 in acute lung injury Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Mesenchymal lineage formation in the lung during development and disease Source: International Congress 2017 – Molecular pathways in lung development Year: 2017 Characterization of human mesenchymal stem cells phenotype and secretome in a in vitro model of acute lung injury inflammation Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011 The new-defined mesenchymal stromal/stem cell marker has a protective role in the development of acute lung injury. Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling Year: 2019 Successful transplantation of rat mesenchymal stem cells, for the therapy of bleomycin induced lung injury Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis Year: 2010 Reduction of lung injury and fibrosis by human embrionic stem cells in a mouse model of silica-induced lung fibrosis Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases Year: 2011